Novel Methylcobalamin Nasal Spray versus Intramuscular Injection: A Randomized, Crossover Comparative Bioavailability Study

International journal of endocrinology and metabolic disorders Pub Date : 2021-01-01 DOI:10.16966/2380-548X.171

H. Dave, Agarwal, A. Maseeh, Patel Kr

引用次数: 1

Abstract

Background/Objective: Methylcobalamin Nasal Spray (NasoB12®, Troikaa, India) has been recently developed to overcome the drawbacks of currently available therapeutic routes. This study was designed to compare pharmacokinetics, safety and tolerability of methylcobalamin nasal spray with intramuscular injection.

查看原文本刊更多论文

新型甲钴胺素鼻喷雾剂与肌内注射:一项随机交叉比较生物利用度研究

背景/目的:甲基钴胺素鼻喷雾剂(NasoB12®，Troikaa，印度)是最近开发的，以克服目前可用的治疗途径的缺点。本研究旨在比较甲钴胺素鼻喷雾剂与肌内注射的药代动力学、安全性和耐受性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of endocrinology and metabolic disorders

自引率

0.00%

发文量